发明名称 (+)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE, COMPOSITIONS AND USES THEREOF
摘要 <p>The present invention relates to (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane and pharmaceutically acceptable salts thereof compositions comprising (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or a pharmaceutically acceptable salt thereof, and methods for treating of or preventing relapse of depression, anxiety disorders, eating disorders, or urinary incontinence in a patient comprising administering (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or a pharmaceutically acceptable salt thereof. The (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or pharmaceutically acceptable salt therof is preferably substantially free of its corresponding (-)-enantiomer.</p>
申请公布号 WO02066427(A3) 申请公布日期 2003.03.13
申请号 WO2002US00845 申请日期 2002.01.11
申请人 DOV PHARMACEUTICAL, INC.;LIPPA, ARNOLD, STAN;EPSTEIN, JOSEPH, WILLIAM 发明人 LIPPA, ARNOLD, STAN;EPSTEIN, JOSEPH, WILLIAM
分类号 A61K45/00;A61K31/40;A61K31/403;A61K31/407;A61K45/06;A61P1/14;A61P3/04;A61P7/12;A61P13/10;A61P25/00;A61P25/18;A61P25/22;A61P25/24;A61P25/30;A61P25/32;C07D209/52;C07D471/08;(IPC1-7):C07D209/52 主分类号 A61K45/00
代理机构 代理人
主权项
地址